TrialClinical genitourinary cancer2017

Dynamic Contrast-Enhanced Magnetic Resonance Imaging as a Pharmacodynamic Biomarker for Pazopanib in Metastatic Renal Carcinoma.

Randy F Sweis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.